temozolomide has been researched along with P carinii Pneumonia in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-grade glioma patients receiving concomitant chemoradiotherapy with temozolomide 75mg/m(2) during six to seven weeks or dose-dense temozolomide regimens especially in combination with chronic use of corticosteroids have a high risk for developing Pneumocystis jirovecii pneumonia." | 8.89 | Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas. ( Bleeker-Rovers, CP; De Vos, FY; Gijtenbeek, JM; van Herpen, CM, 2013) |
| "Temozolomide is utilized as a treatment for a variety of solid tumors and has been associated with the development of selective lymphopenia." | 7.74 | Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. ( Baden, LR; Kulke, MH; Michelini, A; Schwarzberg, AB; Sengupta, T; Stover, EH; Vincitore, M, 2007) |
| "Severe temozolomide-induced immunosuppression, exacerbated by corticosteroids, with profound T-cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma." | 7.73 | Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide. ( Bally, F; Christen, G; de Ribaupierre, S; Ganière, V; Guillou, L; Pica, A; Stupp, R, 2006) |
| "High-grade glioma patients receiving concomitant chemoradiotherapy with temozolomide 75mg/m(2) during six to seven weeks or dose-dense temozolomide regimens especially in combination with chronic use of corticosteroids have a high risk for developing Pneumocystis jirovecii pneumonia." | 4.89 | Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas. ( Bleeker-Rovers, CP; De Vos, FY; Gijtenbeek, JM; van Herpen, CM, 2013) |
| "Prophylaxis against Pneumocystis jiroveci pneumonia (PJP) is currently recommended for patients receiving chemoradiation with temozolomide for newly diagnosed glioblastoma multiforme." | 3.80 | Incidence of Pneumocystis jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis. ( Barnes, PD; Bubalo, J; Fu, R; Gahramanov, S; Lacy, C; Nasseri, M; Neuwelt, AJ; Neuwelt, EA; Nguyen, TM; Tyson, RM, 2014) |
| "Temozolomide is an oral alkylating agent recently approved for the treatment of glioblastoma multiforme." | 3.74 | Temozolomide-associated organizing pneumonitis. ( Aubrey, MC; Lim, KG; Limper, AH; Maldonado, F, 2007) |
| "Temozolomide is utilized as a treatment for a variety of solid tumors and has been associated with the development of selective lymphopenia." | 3.74 | Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. ( Baden, LR; Kulke, MH; Michelini, A; Schwarzberg, AB; Sengupta, T; Stover, EH; Vincitore, M, 2007) |
| "Severe temozolomide-induced immunosuppression, exacerbated by corticosteroids, with profound T-cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma." | 3.73 | Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide. ( Bally, F; Christen, G; de Ribaupierre, S; Ganière, V; Guillou, L; Pica, A; Stupp, R, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Climans, SA | 1 |
| Grunfeld, E | 1 |
| Mason, WP | 1 |
| Chan, KKW | 1 |
| Balzarini, L | 1 |
| Mancini, C | 1 |
| Marvisi, M | 1 |
| Neuwelt, AJ | 1 |
| Nguyen, TM | 1 |
| Fu, R | 1 |
| Bubalo, J | 1 |
| Tyson, RM | 1 |
| Lacy, C | 1 |
| Gahramanov, S | 1 |
| Nasseri, M | 1 |
| Barnes, PD | 1 |
| Neuwelt, EA | 1 |
| Gorospe Sarasúa, L | 1 |
| Ureña-Vacas, A | 1 |
| Muñoz Del Toro, JR | 1 |
| De Vos, FY | 1 |
| Gijtenbeek, JM | 1 |
| Bleeker-Rovers, CP | 1 |
| van Herpen, CM | 1 |
| Ganière, V | 1 |
| Christen, G | 1 |
| Bally, F | 1 |
| Guillou, L | 1 |
| Pica, A | 1 |
| de Ribaupierre, S | 1 |
| Stupp, R | 1 |
| Maldonado, F | 1 |
| Limper, AH | 1 |
| Lim, KG | 1 |
| Aubrey, MC | 1 |
| Schwarzberg, AB | 1 |
| Stover, EH | 1 |
| Sengupta, T | 1 |
| Michelini, A | 1 |
| Vincitore, M | 1 |
| Baden, LR | 1 |
| Kulke, MH | 1 |
| Yu, SK | 1 |
| Chalmers, AJ | 1 |
1 review available for temozolomide and P carinii Pneumonia
| Article | Year |
|---|---|
Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; Dacarbazine; Gliom | 2013 |
8 other studies available for temozolomide and P carinii Pneumonia
| Article | Year |
|---|---|
Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy.
Topics: Anti-Bacterial Agents; Chemoradiotherapy; Humans; Pneumonia, Pneumocystis; Retrospective Studies; Te | 2022 |
A fatal case of acute interstitial pneumonia (AIP) in a woman affected by glioblastoma.
Topics: Aged; Antineoplastic Agents, Alkylating; Blood Gas Analysis; Brain Neoplasms; Bronchoalveolar Lavage | 2014 |
Incidence of Pneumocystis jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chil | 2014 |
Pneumocystis jirovecii pneumonia complicating the progress of a patient with glioblastoma multiforme receiving temozolomide.
Topics: Adrenal Cortex Hormones; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemothera | 2016 |
Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide.
Topics: Antineoplastic Agents, Alkylating; Brain Abscess; Brain Neoplasms; Dacarbazine; Glioblastoma; Humans | 2006 |
Temozolomide-associated organizing pneumonitis.
Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; Glioblastoma; Humans; Male; Pneum | 2007 |
Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Cytomegalovirus Infections; Dacarbazine; Female; Her | 2007 |
Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia.
Topics: Adrenal Cortex Hormones; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; CD4 Lymphocyte C | 2007 |